DIFFUSE LUNG DISEASE OF UNKNOWN ETIOLOGY
Rheumatoid arthritis is associated with five different pulmonary manifestations present in a high percentage of seropositive cases: exudative pleural effusion characterized by a very low glucose concentration; pulmonary nodules varying from a few millimeters to greater than 5 cm in diameter; rheumatoid nodules in association with coal workers’ pneumoconiosis (Caplan’s syndrome); diffuse interstitial fibrosis; and pulmonary vasculitis. With the exception of the nodules and the low glucose in the pleural fluid, patients with systemic lupus erythematosus (SLE) may have many of the same manifestations. Pleuritis and pneumonitis have also been described in Sjogren’s syndrome, polymyositis, and dermato-myositis. The lung is commonly involved in scleroderma presenting as pulmonary fibrosis and/or pulmonary hypertension.
- Pulmonary Hemorrhagic Disorders
- POSTCAPILLARY PULMONARY HYPERTENSION
- PHYSIOLOGICAL EFFECTS OF PULMONARY HYPERTENSION ON CARDIAC FUNCTION
- EMBOLIC DISEASE
- HYPERKINETIC PULMONARY HYPERTENSION
- Other Clearly Extrinsic Causes of Diffuse Infiltrative Lung Disease
- SPECIFIC ENTITIES - DISEASES WITH KFiOWIi ETIOLOGIES -
- Sarcoidosis
- DIFFUSE LUNG DISEASE OF UNKNOWN ETIOLOGY
- CAUSES OF PULMONARY HYPERTENSION
- Miscellaneous
- DIFFUSE INFILTRATIVE DISEASES OF THE LUNG
- CLINICAL MANIFESTATIONS
- Hypersensitivity Pneumonitis
- EFFECTS OF PULMONARY HYPERTENSION ON PULMONARY FUNCTION
- OBLITERATIVE OR OBSTRUCTIVE PULMONARY HYPERTENSION
- TREATMENT
- Idiopathic Pulmonary Fibrosis
- Pulmonary Infiltrates with Eosinophilia PIE
- CLINICAL FEATURES OF PULMONARY HYPERTENSION
- Pulmonary Vasculitis